Sign Out
No interaction studies have been performed. For the treatment of GPP flares, spesolimab is not expected to cause cytokine mediated CYP interaction as a perpetrator.
Live vaccines should not be given concurrently with spesolimab (see Precautions).
There is limited experience from the use of spesolimab in combination with immunosuppressants in GPP patients (see Precautions).
